A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
NCT06905873 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2025-11-20
Summary
A Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Non-Segmental Vitiligo.
Conditions
- Vitiligo
Interventions
- DRUG
-
FB102
Route of administration- Intravenous (IV)
- DRUG
-
Route of administration- Intravenous (IV)
Sponsors & Collaborators
-
Forte Biosciences, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-25
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Australia
- New Zealand
Study Locations
More Related Trials
-
Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.
NCT06446063 ·Status: TERMINATED
-
Topical Methotrexate with Fractional CO2 Laser in Treatment of Non Segmental Vitiligo
NCT06877455 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
NCT04774809 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
NCT04942860 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
NCT03715829 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
NCT02506101 ·Status: TERMINATED ·Phase: NA
-
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
NCT07307534 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
NCT06113328 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
NCT03468855 ·Status: COMPLETED ·Phase: PHASE2
-
Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo
NCT05008887 ·Status: UNKNOWN ·Phase: PHASE4
-
Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
NCT00907062 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
NCT05037981 ·Status: COMPLETED
-
Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas
NCT05872477 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients
NCT06593197 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo
NCT03487042 ·Status: UNKNOWN ·Phase: PHASE4
-
Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo
NCT03158675 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
NCT04103060 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
NCT04237103 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
NCT04811131 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
NCT06991972 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo
NCT07044141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo
NCT06974669 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Role of Tofacitinib in Vitiligo Patients
NCT05293119 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
NCT04525157 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo
NCT06394349 ·Status: RECRUITING ·Phase: NA